Connection

Scott Boyd to Spike Glycoprotein, Coronavirus

Back to Details
This is a "connection" page, showing publications Scott Boyd has written about Spike Glycoprotein, Coronavirus.
Scott Boyd
Connection Strength
0.142
Spike Glycoprotein, Coronavirus
  1. Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results. Clin Chem. 2021 07 06; 67(7):977-986.
    View in: PubMed
    Score: 0.026
  2. Antibody and B cell responses to SARS-CoV-2 infection and vaccination. Cell Host Microbe. 2021 07 14; 29(7):1063-1075.
    View in: PubMed
    Score: 0.026
  3. Serial SARS-CoV-2 Receptor-Binding Domain Antibody Responses in Patients Receiving Dialysis. Ann Intern Med. 2021 08; 174(8):1073-1080.
    View in: PubMed
    Score: 0.026
  4. Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome. Sci Immunol. 2020 12 07; 5(54).
    View in: PubMed
    Score: 0.025
  5. Human B Cell Clonal Expansion and Convergent Antibody Responses to SARS-CoV-2. Cell Host Microbe. 2020 10 07; 28(4):516-525.e5.
    View in: PubMed
    Score: 0.025
  6. Systems vaccinology of the BNT162b2 mRNA vaccine in humans. Nature. 2021 08; 596(7872):410-416.
    View in: PubMed
    Score: 0.007
  7. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity. Nature. 2021 06; 594(7862):253-258.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.